Preclinical Evaluation of the Short-Term Toxicity of 4-(N)-Docosahexaenoyl 2´, 2´- Difluorodeoxycytidine (DHA-dFdC).
about
Preclinical Evaluation of the Short-Term Toxicity of 4-(N)-Docosahexaenoyl 2´, 2´- Difluorodeoxycytidine (DHA-dFdC).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Preclinical Evaluation of the ...... luorodeoxycytidine (DHA-dFdC).
@en
Preclinical Evaluation of the ...... luorodeoxycytidine (DHA-dFdC).
@nl
type
label
Preclinical Evaluation of the ...... luorodeoxycytidine (DHA-dFdC).
@en
Preclinical Evaluation of the ...... luorodeoxycytidine (DHA-dFdC).
@nl
prefLabel
Preclinical Evaluation of the ...... luorodeoxycytidine (DHA-dFdC).
@en
Preclinical Evaluation of the ...... luorodeoxycytidine (DHA-dFdC).
@nl
P2093
P2860
P1476
Preclinical Evaluation of the ...... fluorodeoxycytidine (DHA-dFdC)
@en
P2093
Christopher A Jolly
Rick A Finch
Solange Valdes
Wallace B Baze
Zhengrong Cui
P2860
P304
P356
10.1007/S11095-017-2139-X
P577
2017-03-28T00:00:00Z